UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 12, 2025 (May 7, 2025)

CLARIVATE PLC 

(Exact name of registrant as specified in its charter)

Jersey, Channel Islands

(State or other jurisdiction of incorporation or organization)

70 St. Mary Axe

London EC3A 8BE
United Kingdom

(Address of Principal Executive Offices)(Zip Code)

(44) 207-433-4000

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Exchange Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

On May 7, 2025, Clarivate Plc (“Clarivate” or the “Company”) held its 2025 Annual General Meeting of Shareholders.

At that meeting, the shareholders considered and acted upon five proposals pursuant to the Notice of Annual General Meeting of Shareholders and as described in more detail in the Company’s definitive proxy statement dated March 28, 2025 (the “Proxy Statement”).

Of 688,956,113 ordinary shares outstanding and entitled to vote as of March 10, 2025 (the “Record Date”), the holders of 659,171,835 ordinary shares were present at the meeting either in person or by proxy, constituting a quorum.

All proposals on the agenda were approved by the shareholders.

Below are the final voting results. In tabulating the voting results, only FOR or AGAINST votes are counted. Broker non-votes and abstentions are counted only for purposes of determining whether a quorum is present.

Proposal 1: Election of Directors

Shareholders elected the individuals named below to serve as directors of the Company, until the Company’s 2026 Annual General Meeting, or until their successor is duly elected and qualified, or their earlier resignation or removal. Election of each director required approval by a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

Proposal 2: Advisory Approval of Executive Compensation

Shareholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. Approval required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

Proposal 3: Ratification of Appointment of Independent Registered Public Accountants

Shareholders reappointed PricewaterhouseCoopers LLP as the Company’s auditors, ratified their appointment as the Company’s independent registered public accountants for the fiscal year 2025 on a non-binding and advisory basis, and authorized the Company’s Board of Directors, acting through its Audit Committee, to determine the fees to be paid to the auditors. Ratification required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

Proposal 4: Approval of the Clarivate Plc Amended and Restated 2019 Incentive Award Plan

Shareholders approved the Clarivate Plc Amended and Restated 2019 Incentive Award Plan. Approval required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

Proposal 5: Authorization to Repurchase the Company’s Ordinary Shares in Open-Market Transactions

Shareholders authorized the Company to conduct open-market purchases of its ordinary shares from time to time as approved by the Board of Directors. The first resolution pursuant to Proposal 5 was approved as a special resolution that required at least two-thirds of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy. The second resolution pursuant to Proposal 5 was an ordinary resolution that required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

Date of 2026 Annual General Meeting of Shareholders

Clarivate’s 2026 Annual General Meeting of Shareholders will be held on May 14, 2026. Further details will be provided in the proxy statement for the meeting.

(d) Exhibits

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.